Back
Kiniksa Pharmaceuticals Stock Price Chart
Is Elon Musk right about AI?
Learn all about it here.
Buy
69
KNSA
Kiniksa Pharmaceuticals
Last Price:
17.77
Seasonality Move:
11.18%
7 Day Trial
ALL ACCESS PASS
$
7
Big Gains Still to Be Had in 2023
Grab a FREE ticket right now on this page!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KNSA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Kiniksa Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.55 | Buy |
| 20-day SMA: | 17.33 | Buy |
| 50-day SMA: | 16.47 | Buy |
| 200-day SMA: | 14.42 | Buy |
| 8-day EMA: | 17.48 | Buy |
| 20-day EMA: | 17.37 | Buy |
| 50-day EMA: | 16.65 | Buy |
| 200-day EMA: | 14.53 | Buy |
Kiniksa Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 55.78 | Buy |
| Chaikin Money Flow: | 147612 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.89 - 18.35) | Buy |
| Bollinger Bands (100): | (12.75 - 17.29) | Buy |
Kiniksa Pharmaceuticals Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kiniksa Pharmaceuticals Stock
Is Kiniksa Pharmaceuticals Stock a Buy?
- Kiniksa Pharmaceuticals share price is 17.76 while KNSA 8-day simple moving average is 17.55, which is a Buy signal.
- The stock price of KNSA is 17.76 while Kiniksa Pharmaceuticals 20-day SMA is 17.33, which makes it a Buy.
- Kiniksa Pharmaceuticals 50-day simple moving average is 16.47 while KNSA share price is 17.76, making it a Buy technically.
- KNSA stock price is 17.76 and Kiniksa Pharmaceuticals 200-day simple moving average is 14.42, creating a Buy signal.
KNSA Technical Analysis vs Fundamental Analysis
Buy
69
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Is Kiniksa Pharmaceuticals a Buy or a Sell?
-
Kiniksa Pharmaceuticals stock is rated a Buy
The current Kiniksa Pharmaceuticals [KNSA] share price is $17.76. The Score for KNSA is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Kiniksa Pharmaceuticals Stock Info
Market Cap:
1.25B
Price in USD:
17.76
Share Volume:
251.34K
Kiniksa Pharmaceuticals 52-Week Range
52-Week High:
20.65
52-Week Low:
10.14
Buy
69
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Kiniksa Pharmaceuticals Share Price Forecast
-
What is the Kiniksa Pharmaceuticals stock price today?
The Kiniksa Pharmaceuticals stock price is 17.76 USD today. -
Will KNSA stock go up or go down?
Kiniksa Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Kiniksa Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kiniksa Pharmaceuticals is not overvalued.
Is Kiniksa Pharmaceuticals Stock a Buy?
- Kiniksa Pharmaceuticals share price is 17.76 while KNSA 8-day exponential moving average is 17.48, which is a Buy signal.
- The stock price of KNSA is 17.76 while Kiniksa Pharmaceuticals 20-day EMA is 17.37, which makes it a Buy.
- Kiniksa Pharmaceuticals 50-day exponential moving average is 16.65 while KNSA share price is 17.76, making it a Buy technically.
- KNSA stock price is 17.76 and Kiniksa Pharmaceuticals 200-day simple moving average is 14.53, creating a Buy signal.
Fundamental Analysis of Kiniksa Pharmaceuticals
Is Kiniksa Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.99 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.81 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Kiniksa Pharmaceuticals
Should I short Kiniksa Pharmaceuticals stock?
- KNSA Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Kiniksa Pharmaceuticals is a Buy
- Kiniksa Pharmaceuticals Relative Strength Index (RSI) is 55.78, which suggest Kiniksa Pharmaceuticals is overbought
- The Bollinger Bands (25) for Kiniksa Pharmaceuticals is (16.89 - 18.35), which suggest Kiniksa Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Kiniksa Pharmaceuticals is (12.75 - 17.29), which suggest Kiniksa Pharmaceuticals is a Buy
* Kiniksa Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.